BTP2   Click here for help

GtoPdb Ligand ID: 2438

Synonyms: YM-58483
Immunopharmacology Ligand
Compound class: Synthetic organic
Comment: BTP2 (YM-58483) is a small molecule store-operated Ca2+ release-activated Ca2+ (CRAC) channel inhibitor [2].
Click here for help
2D Structure
Click here for help
Click here for structure editor
Physico-chemical Properties
Click here for help
Hydrogen bond acceptors 5
Hydrogen bond donors 1
Rotatable bonds 6
Topological polar surface area 100.42
Molecular weight 421.04
XLogP 3.51
No. Lipinski's rules broken 0
SMILES / InChI / InChIKey
Click here for help
Canonical SMILES O=C(c1snnc1C)Nc1ccc(cc1)n1nc(cc1C(F)(F)F)C(F)(F)F
Isomeric SMILES O=C(c1snnc1C)Nc1ccc(cc1)n1nc(cc1C(F)(F)F)C(F)(F)F
InChI InChI=1S/C15H9F6N5OS/c1-7-12(28-25-23-7)13(27)22-8-2-4-9(5-3-8)26-11(15(19,20)21)6-10(24-26)14(16,17)18/h2-6H,1H3,(H,22,27)
InChI Key XPRZIORDEVHURQ-UHFFFAOYSA-N
References
1. He LP, Hewavitharana T, Soboloff J, Spassova MA, Gill DL. (2005)
A functional link between store-operated and TRPC channels revealed by the 3,5-bis(trifluoromethyl)pyrazole derivative, BTP2.
J Biol Chem, 280 (12): 10997-1006. [PMID:15647288]
2. Liu S, Hasegawa H, Takemasa E, Suzuki Y, Oka K, Kiyoi T, Takeda H, Ogasawara T, Sawasaki T, Yasukawa M et al.. (2017)
Efficiency and Safety of CRAC Inhibitors in Human Rheumatoid Arthritis Xenograft Models.
J Immunol, 199 (5): 1584-1595. [PMID:28716825]
3. Takezawa R, Cheng H, Beck A, Ishikawa J, Launay P, Kubota H, Kinet JP, Fleig A, Yamada T, Penner R. (2006)
A pyrazole derivative potently inhibits lymphocyte Ca2+ influx and cytokine production by facilitating transient receptor potential melastatin 4 channel activity.
Mol Pharmacol, 69 (4): 1413-20. [PMID:16407466]
4. Tian C, Du L, Zhou Y, Li M. (2016)
Store-operated CRAC channel inhibitors: opportunities and challenges.
Future Med Chem, 8 (7): 817-32. [PMID:27149324]